NexturnBioscience Co. Ltd
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more
NexturnBioscience Co. Ltd (089140) - Total Assets
Latest total assets as of September 2025: ₩368.91 Billion KRW
Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) holds total assets worth ₩368.91 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NexturnBioscience Co. Ltd - Total Assets Trend (2014–2024)
This chart illustrates how NexturnBioscience Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NexturnBioscience Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
NexturnBioscience Co. Ltd's total assets of ₩368.91 Billion consist of 22.8% current assets and 77.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩10.60 Billion | 0.0% |
| Accounts Receivable | ₩3.92 Billion | 1.7% |
| Inventory | ₩8.44 Billion | 3.6% |
| Property, Plant & Equipment | ₩27.23 Billion | 11.7% |
| Intangible Assets | ₩993.90 Million | 0.4% |
| Goodwill | ₩1.66 Billion | 0.7% |
Asset Composition Trend (2014–2024)
This chart illustrates how NexturnBioscience Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NexturnBioscience Co. Ltd's current assets represent 22.8% of total assets in 2024, a decrease from 75.7% in 2014.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 31.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 11.7% of total assets.
NexturnBioscience Co. Ltd Competitors by Total Assets
Key competitors of NexturnBioscience Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Al-Ghazi Tractors Ltd
KAR:AGTL
|
Pakistan | PKRs17.88 Billion |
|
Bosung Power Technology Co. Ltd
KQ:006910
|
Korea | ₩135.72 Billion |
|
Youngsin Metal Industrial Co. Ltd
KQ:007530
|
Korea | ₩147.89 Billion |
|
SMCore.Inc
KQ:007820
|
Korea | ₩111.26 Billion |
|
Heungkuk Metaltech Co.Ltd
KQ:010240
|
Korea | ₩134.35 Billion |
|
Nuintek Co.Ltd
KQ:012340
|
Korea | ₩79.96 Billion |
|
CAS Corporation
KQ:016920
|
Korea | ₩171.45 Billion |
|
Semyung Electric Machinery Co.Ltd
KQ:017510
|
Korea | ₩107.57 Billion |
NexturnBioscience Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NexturnBioscience Co. Ltd generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NexturnBioscience Co. Ltd is currently not profitable relative to its asset base.
NexturnBioscience Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 2.10 | 32.29 |
| Quick Ratio | 0.75 | 1.76 | 28.91 |
| Cash Ratio | 0.00 | 0.43 | 0.00 |
| Working Capital | ₩6.85 Billion | ₩ 26.34 Billion | ₩ 64.72 Billion |
NexturnBioscience Co. Ltd - Advanced Valuation Insights
This section examines the relationship between NexturnBioscience Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.26 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.5% |
| Total Assets | ₩233.04 Billion |
| Market Capitalization | $26.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values NexturnBioscience Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: NexturnBioscience Co. Ltd's assets decreased by 4.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for NexturnBioscience Co. Ltd (2014–2024)
The table below shows the annual total assets of NexturnBioscience Co. Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩233.04 Billion | -4.49% |
| 2023-12-31 | ₩243.99 Billion | +21.84% |
| 2022-12-31 | ₩200.26 Billion | +44.12% |
| 2021-12-31 | ₩138.95 Billion | +39.86% |
| 2020-12-31 | ₩99.35 Billion | -5.53% |
| 2019-12-31 | ₩105.17 Billion | -7.36% |
| 2018-12-31 | ₩113.52 Billion | +19.81% |
| 2017-12-31 | ₩94.75 Billion | -3.84% |
| 2016-12-31 | ₩98.53 Billion | +196.70% |
| 2015-12-31 | ₩33.21 Billion | -0.82% |
| 2014-12-31 | ₩33.48 Billion | -- |